201 related articles for article (PubMed ID: 32862371)
1. Impact of Neoadjuvant Therapy on Minimally Invasive Surgical Outcomes in Advanced Gastric Cancer: An International Propensity Score-Matched Study.
Yan Y; Yang A; Lu L; Zhao Z; Li C; Li W; Chao J; Liu T; Fong Y; Fu W; Woo Y
Ann Surg Oncol; 2021 Mar; 28(3):1428-1436. PubMed ID: 32862371
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic analysis of neoadjuvant chemotherapy for locally advanced gastric cancer with propensity score matching method].
Peng L; Yang W; Zhang Z; Zhi C; Zhou X; Liu H; Hua Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1148-1153. PubMed ID: 30370514
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of robotic-assisted versus laparoscopic distal gastrectomy after neoadjuvant chemotherapy for advanced gastric cancer.
Tian Y; Guo H; Hu Y; Yang P; Liu Y; Zhang Z; Ding P; Zheng T; Fan L; Zhang Z; Li Y; Zhao Q
Surg Endosc; 2023 Sep; 37(9):6761-6770. PubMed ID: 37221415
[TBL] [Abstract][Full Text] [Related]
4. Impact of Neoadjuvant Chemotherapy Among Patients with Pancreatic Fistula After Gastrectomy for Advanced Gastric Cancer.
Kosaka T; Akiyama H; Makino H; Kimura J; Takagawa R; Ono HA; Kunisaki C; Endo I
Anticancer Res; 2016 Apr; 36(4):1773-7. PubMed ID: 27069158
[TBL] [Abstract][Full Text] [Related]
5. Assessment of indocyanine green tracer-guided lymphadenectomy in laparoscopic gastrectomy after neoadjuvant chemotherapy for locally advanced gastric cancer: results from a multicenter analysis based on propensity matching.
Huang ZN; Su-Yan ; Qiu WW; Liu CH; Chen QY; Zheng CH; Li P; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Lin JL; Zheng HL; Lin GT; Huang CM
Gastric Cancer; 2021 Nov; 24(6):1355-1364. PubMed ID: 34387763
[TBL] [Abstract][Full Text] [Related]
6. Study protocol of a multicenter phase III randomized controlled trial investigating the efficiency of the combination of neoadjuvant chemotherapy (NAC) and neoadjuvant laparoscopic intraperitoneal hyperthermic chemotherapy (NLHIPEC) followed by R0 gastrectomy with intraoperative HIPEC for advanced gastric cancer (AGC): dragon II trial.
Beeharry MK; Ni ZT; Yang ZY; Zheng YN; Feng RH; Liu WT; Yan C; Yao XX; Li C; Yan M; Zhu ZG
BMC Cancer; 2020 Mar; 20(1):224. PubMed ID: 32183736
[TBL] [Abstract][Full Text] [Related]
7. Short-term outcomes of gastrectomy after neoadjuvant chemotherapy for clinical stage III gastric cancer: propensity score-matched analysis of a multi-institutional database.
Umeda S; Kanda M; Nakanishi K; Ito S; Mochizuki Y; Teramoto H; Ishigure K; Murai T; Asada T; Ishiyama A; Matsushita H; Shimizu D; Kobayashi D; Tanaka C; Fujiwara M; Murotani K; Kodera Y
Surg Today; 2021 May; 51(5):821-828. PubMed ID: 33170366
[TBL] [Abstract][Full Text] [Related]
8. [Postoperative complications and their influence on the prognosis factors in gastric cancer patients receiving neoadjuvant treatment].
Wang TB; Mao QK; Zhang XJ; Zhou H; Guo CG; Chen YT; Zhao DB
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):160-166. PubMed ID: 33508922
[No Abstract] [Full Text] [Related]
9. Long-Term Survival after Minimally Invasive Versus Open Gastrectomy for Gastric Adenocarcinoma: A Propensity Score-Matched Analysis of Patients in the United States and China.
Lu J; Yoon C; Xu B; Xie J; Li P; Zheng C; Huang C; Yoon SS
Ann Surg Oncol; 2020 Mar; 27(3):802-811. PubMed ID: 31894481
[TBL] [Abstract][Full Text] [Related]
10. Safety and short-term outcomes of laparoscopic surgery for advanced gastric cancer after neoadjuvant immunotherapy: A retrospective cohort study.
Su J; Guo W; Chen Z; Wang L; Liu H; Zhao L; Lin T; Li F; Mao X; Huang H; Yu J; Li G; Hu Y
Front Immunol; 2022; 13():1078196. PubMed ID: 36569865
[TBL] [Abstract][Full Text] [Related]
11. Long- and short-term outcomes of laparoscopic gastrectomy versus open gastrectomy in patients with clinically and pathological locally advanced gastric cancer: a propensity-score matching analysis.
Inokuchi M; Nakagawa M; Tanioka T; Okuno K; Gokita K; Kojima K
Surg Endosc; 2018 Feb; 32(2):735-742. PubMed ID: 28726137
[TBL] [Abstract][Full Text] [Related]
12. Severity of complications and long-term survival after laparoscopic total gastrectomy with D2 lymph node dissection for advanced gastric cancer: A propensity score-matched, case-control study.
Li Z; Bai B; Zhao Y; Yu D; Lian B; Liu Y; Zhao Q
Int J Surg; 2018 Jun; 54(Pt A):62-69. PubMed ID: 29698790
[TBL] [Abstract][Full Text] [Related]
13. Survival Benefit of Neoadjuvant Chemotherapy with S-1 Plus Docetaxel for Locally Advanced Gastric Cancer: A Propensity Score-Matched Analysis.
Kano M; Hayano K; Hayashi H; Hanari N; Gunji H; Toyozumi T; Murakami K; Uesato M; Ota S; Matsubara H
Ann Surg Oncol; 2019 Jun; 26(6):1805-1813. PubMed ID: 30977014
[TBL] [Abstract][Full Text] [Related]
14. Severity and incidence of complications assessed by the Clavien-Dindo classification following robotic and laparoscopic gastrectomy for advanced gastric cancer: a retrospective and propensity score-matched study.
Wang WJ; Li HT; Yu JP; Su L; Guo CA; Chen P; Yan L; Li K; Ma YW; Wang L; Hu W; Li YM; Liu HB
Surg Endosc; 2019 Oct; 33(10):3341-3354. PubMed ID: 30560498
[TBL] [Abstract][Full Text] [Related]
15. Non-robotic minimally invasive gastrectomy as an independent risk factor for postoperative intra-abdominal infectious complications: A single-center, retrospective and propensity score-matched analysis.
Shibasaki S; Suda K; Nakauchi M; Nakamura K; Kikuchi K; Inaba K; Uyama I
World J Gastroenterol; 2020 Mar; 26(11):1172-1184. PubMed ID: 32231421
[TBL] [Abstract][Full Text] [Related]
16. Effects of Neoadjuvant Chemotherapy Toxicity and Postoperative Complications on Short-term and Long-term Outcomes After Curative Resection of Gastric Cancer.
Wu C; Wang N; Zhou H; Wang T; Mao Q; Zhang X; Zhao D
J Gastrointest Surg; 2020 Jun; 24(6):1278-1289. PubMed ID: 31140064
[TBL] [Abstract][Full Text] [Related]
17. Minimally invasive surgery as a treatment option for gastric cancer with liver metastasis: a comparison with open surgery.
Li J; Xi H; Cui J; Zhang K; Gao Y; Liang W; Cai A; Wei B; Chen L
Surg Endosc; 2018 Mar; 32(3):1422-1433. PubMed ID: 29075971
[TBL] [Abstract][Full Text] [Related]
18. Postoperative morbidity and mortality after neoadjuvant chemotherapy versus upfront surgery for locally advanced gastric cancer: a propensity score matching analysis.
Wu L; Ge L; Qin Y; Huang M; Chen J; Yang Y; Zhong J
Cancer Manag Res; 2019; 11():6011-6018. PubMed ID: 31308742
[TBL] [Abstract][Full Text] [Related]
19. [Risk factors of postoperative complication after total gastrectomy in advanced gastric cancer patients receiving neoadjuvant chemotherapy].
Cui H; Zhang KC; Cao B; Deng H; Liu GX; Cui JX; Xie TY; Liang WQ; Zhang QP; Wang N; Chen L; Wei B
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):153-159. PubMed ID: 33508921
[No Abstract] [Full Text] [Related]
20. Neoadjuvant chemotherapy
Li Y; Ma FH; Xue LY; Tian YT
World J Gastroenterol; 2020 Feb; 26(8):818-827. PubMed ID: 32148379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
